
We are a global leader in cardiology and have chosen to become a focused and innovative player in oncology by 2030, targeting difficult-to-treat cancers.
We are a pharmaceutical group with a human touch, international and independent, governed by a Foundation. We are 22,000 passionate people from over 50 nationalities, driven by an entrepreneurial spirit.
We are a global leader in cardiology and have chosen to become a focused and innovative player in oncology by 2030, targeting difficult-to-treat cancers.